Increased Antipyrine Half-Life in Women Taking Oral Contraceptives

Abstract

The plasma half-life of antipyrine has been measured in 18 women taking oral contraceptives and in 19 control subjects. The mean half-life in the oral contraceptive group of 13.2±2.0 hr. was significantly prolonged compared to the control value of 10.5±2.5 hours

Get full access to this article

View all access options for this article.

References

Brodie

B. B.

Axelrod

(1950). The fate of antipyrine in man. Journal of Pharmacology and Therapeutics, 98, 97

Brodie

B. B.

Axelrod

Soberman

Levy'

B. B.

(1949). The estimation of antipyrine in biological materials. Journal of Biological Chemistry, 179, 25

Conney

A. H.

(1967). Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews, 19, 317

Crawford

J. J.

Rudofsky

(1966). Some alterations in the pattern of drug metabolism associated with pregnancy, oral contraceptives and the newly born. British Journal of Anaesthetics, 38, 446

Jori

Bianchetti

Prestini

(1969). Effects of contraceptive agents on drug metabolism. European Journal of Pharmacology, 7, 196

Juchau

M. R.

Fouts

J. R.

(1966). Effect of norethynodrel and progesterone on hepatic microsomal drug-metabolising enzyme systems. Biochemical Pharmacology, 15, 891

Kolmodin

Azarnoff

D. L.

Sjoqvist

(1969). Effects of environmental factors on drug metabolism: Decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides. Clinical Pharmacology and Therapeutics, 10, 638

Preedy

Aitken

(1956). The effect of estrogen on water and electrolyte metabolism. 1. The normal. Journal of Clinical Investigation, 35, 423

Soberman

Brodie

B. B.

Levy

B. B.

Axelrod

Hollander

(1949). The use of antipyrine in the measurement of total body water in man. Journal of Biological Chemistry, 179, 31

10.

Vessel

Page

(1968). Genetic control of drug levels in man: Antipyrine. Science (Washington), 161, 72

11.

Vessel

Page

(1969). Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. Journal of Clinical Investigation, 48, 2202